Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice
Ina V. Martin(University Hospital Zurich), Andreas Geier(Swiss Integrative Center for Human Health), A Minkenberg(Universitätsklinikum Aachen), Beat Müllhaupt(University Hospital of Zurich), Johannes Schmitt(Universitätsklinikum Würzburg), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Bruno Stieger(University Hospital of Zurich)
Cited by 26
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k